142 related articles for article (PubMed ID: 23357253)
1. Drug-inorganic-polymer nanohybrid for transdermal delivery.
Kim MH; Park DH; Yang JH; Choy YB; Choy JH
Int J Pharm; 2013 Feb; 444(1-2):120-7. PubMed ID: 23357253
[TBL] [Abstract][Full Text] [Related]
2. Inorganic-polymer nanohybrid carrier for delivery of a poorly-soluble drug, ursodeoxycholic acid.
Choi G; Lee JH; Oh YJ; Choy YB; Park MC; Chang HC; Choy JH
Int J Pharm; 2010 Dec; 402(1-2):117-22. PubMed ID: 20933070
[TBL] [Abstract][Full Text] [Related]
3. Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC.
Gonzalez-Mira E; Egea MA; Garcia ML; Souto EB
Colloids Surf B Biointerfaces; 2010 Dec; 81(2):412-21. PubMed ID: 20719479
[TBL] [Abstract][Full Text] [Related]
4. Construction and Evaluation of Hyaluronic Acid-Coated Flurbiprofen-Layered Double Hydroxide Ocular Drug Delivery System.
Gu D; Pan H; Xu S; Chen W; Zhu R; Jiang W; Pan W
AAPS PharmSciTech; 2022 Oct; 23(8):287. PubMed ID: 36266593
[TBL] [Abstract][Full Text] [Related]
5. Dermal flurbiprofen nanosuspensions: Optimization with design of experiment approach and in vitro evaluation.
Oktay AN; Karakucuk A; Ilbasmis-Tamer S; Celebi N
Eur J Pharm Sci; 2018 Sep; 122():254-263. PubMed ID: 29981401
[TBL] [Abstract][Full Text] [Related]
6. Zn-Al-NO(3)-layered double hydroxides with intercalated diclofenac for ocular delivery.
Cao F; Wang Y; Ping Q; Liao Z
Int J Pharm; 2011 Feb; 404(1-2):250-6. PubMed ID: 21093561
[TBL] [Abstract][Full Text] [Related]
7. Nanocomposites of 2-arylpropionic acid drugs based on Mg-Al layered double hydroxide for dissolution enhancement.
Berber MR; Minagawa K; Katoh M; Mori T; Tanaka M
Eur J Pharm Sci; 2008 Nov; 35(4):354-60. PubMed ID: 18789388
[TBL] [Abstract][Full Text] [Related]
8. Potential use of nanostructured lipid carriers for topical delivery of flurbiprofen.
González-Mira E; Nikolić S; García ML; Egea MA; Souto EB; Calpena AC
J Pharm Sci; 2011 Jan; 100(1):242-51. PubMed ID: 20575052
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of skin permeation of flurbiprofen via its transdermal patches using isopulegol decanoate (ISO-C10) as an absorption enhancer: pharmacokinetic and pharmacodynamic evaluation.
Chen Y; Quan P; Liu X; Guo W; Song W; Cun D; Wang Z; Fang L
J Pharm Pharmacol; 2015 Sep; 67(9):1232-9. PubMed ID: 25994482
[TBL] [Abstract][Full Text] [Related]
10. Nanoemulsions as vehicles for transdermal delivery of aceclofenac.
Shakeel F; Baboota S; Ahuja A; Ali J; Aqil M; Shafiq S
AAPS PharmSciTech; 2007 Dec; 8(4):E104. PubMed ID: 18181525
[TBL] [Abstract][Full Text] [Related]
11. Formulation, characterization and in vitro-in vivo evaluation of flurbiprofen-loaded nanostructured lipid carriers for transdermal delivery.
Kawadkar J; Pathak A; Kishore R; Chauhan MK
Drug Dev Ind Pharm; 2013 Apr; 39(4):569-78. PubMed ID: 22639934
[TBL] [Abstract][Full Text] [Related]
12. Multi-laminated metal hydroxide nanocontainers for oral-specific delivery for bioavailability improvement and treatment of inflammatory paw edema in mice.
Kankala RK; Kuthati Y; Sie HW; Shih HY; Lue SI; Kankala S; Jeng CC; Deng JP; Weng CF; Liu CL; Lee CH
J Colloid Interface Sci; 2015 Nov; 458():217-28. PubMed ID: 26225492
[TBL] [Abstract][Full Text] [Related]
13. Does stereochemistry influence transdermal permeation of flurbiprofen through the rat skin?
Valentová J; Bauerová K; Farah L; Devínsky F
Arch Dermatol Res; 2010 Oct; 302(8):635-8. PubMed ID: 20582424
[TBL] [Abstract][Full Text] [Related]
14. Nanostructured lipid carriers (NLC) based topical gel of flurbiprofen: design, characterization and in vivo evaluation.
Han F; Yin R; Che X; Yuan J; Cui Y; Yin H; Li S
Int J Pharm; 2012 Dec; 439(1-2):349-57. PubMed ID: 22989987
[TBL] [Abstract][Full Text] [Related]
15. Pluronic lecithin organogel as a topical drug delivery system.
Pandey M; Belgamwar V; Gattani S; Surana S; Tekade A
Drug Deliv; 2010 Jan; 17(1):38-47. PubMed ID: 22747074
[TBL] [Abstract][Full Text] [Related]
16. Multivariate optimization of formulation variables influencing flurbiprofen proniosomes characteristics.
Zidan AS; Mokhtar M
J Pharm Sci; 2011 Jun; 100(6):2212-21. PubMed ID: 21259237
[TBL] [Abstract][Full Text] [Related]
17. Glyceryl monooleyl ether-based liquid crystalline nanoparticles as a transdermal delivery system of flurbiprofen: characterization and in vitro transport.
Uchino T; Murata A; Miyazaki Y; Oka T; Kagawa Y
Chem Pharm Bull (Tokyo); 2015; 63(5):334-40. PubMed ID: 25948327
[TBL] [Abstract][Full Text] [Related]
18. Ocular delivery of flurbiprofen based on Eudragit(®) E-flurbiprofen complex dispersed in aqueous solution: preparation, characterization, in vitro corneal penetration, and ocular irritation.
Quinteros DA; Tártara LI; Palma SD; Manzo RH; Allemandi DA
J Pharm Sci; 2014 Dec; 103(12):3859-3868. PubMed ID: 25294798
[TBL] [Abstract][Full Text] [Related]
19. Ibuprofen intercalation and release from different layered double hydroxides.
Gaskell EE; Ha T; Hamilton AR
Ther Deliv; 2018 Sep; 9(9):653-666. PubMed ID: 30189806
[TBL] [Abstract][Full Text] [Related]
20. Engineered Cellular Uptake and Controlled Drug Delivery Using Two Dimensional Nanoparticle and Polymer for Cancer Treatment.
Senapati S; Shukla R; Tripathi YB; Mahanta AK; Rana D; Maiti P
Mol Pharm; 2018 Feb; 15(2):679-694. PubMed ID: 29298488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
